Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

BACKGROUND AND OBJECTIVES: The effectiveness and tolerability of tapentadol extended release (ER), a centrally acting analgesic with μ-opioid receptor agonist and norepinephrine (noradrenaline) reuptake inhibitor activities, have been demonstrated in patients with chronic pain, including those switc...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Imanaka, Keiichiro, Tominaga, Yushin, Etropolski, Mila, Ohashi, Hiroki, Hirose, Keiichiro, Matsumura, Taka
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2014
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4062813/
https://ncbi.nlm.nih.gov/pubmed/24906437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-014-0204-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky